Chronic relapsing homologous collagen-induced arthritis in DBA/1 mice as a model for testing disease-modifying and remission-inducing therapies.
OBJECTIVE: To test whether the chronic relapsing arthritis induced by immunizing DBA/1 mice with homologous type II collagen is a valuable model for testing disease-modifying antiarthritic drugs. METHODS: Six-week-old male DBA/1 mice were immunized with murine type II collagen in Freund's compl...
Hlavní autoři: | Malfait, A, Williams, R, Malik, A, Maini, R, Feldmann, M |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2001
|
Podobné jednotky
-
P-selectin glycoprotein ligand 1 therapy ameliorates established collagen-induced arthritis in DBA/1 mice partly through the suppression of tumour necrosis factor.
Autor: Sumariwalla, P, a další
Vydáno: (2004) -
Combination therapy with DMARDs and biological agents in collagen-induced arthritis.
Autor: Williams, R, a další
Vydáno: (1999) -
Blockade of IL-12 during the induction of collagen-induced arthritis (CIA) markedly attenuates the severity of the arthritis.
Autor: Malfait, A, a další
Vydáno: (1998) -
The beta2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: mechanisms of action.
Autor: Malfait, A, a další
Vydáno: (1999) -
Anti-IL-12 and anti-TNF antibodies synergistically suppress the progression of murine collagen-induced arthritis.
Autor: Butler, D, a další
Vydáno: (1999)